DI
CSTL icon

DFPG Investments’s Castle Biosciences CSTL Stock Holding History

DFPG Investments’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$284K Sell
13,649
-766
-5% -$13.5K 0.02% 527
2023
Q3 		$247K Sell
14,415
-1,737
-11% -$30.4K 0.02% 514
2023
Q2 		$276K Buy
+16,152
New +$327K 0.02% 490

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DFPG Investments's CSTL Position: Q4 2023 in Review

DFPG Investments reduced its Castle Biosciences (CSTL) stake by 5.3% in Q4 2023, selling an estimated $13.5K and leaving 13,649 shares worth $284K. The position accounts for 0.02% of the portfolio, ranked #527.

DFPG Investments first reported a position in CSTL in Q2 2023 and has held it in 3 quarters since. 153 funds tracked by Wall St. Rank hold CSTL as of Q4 2023.

  • DFPG Investments held 13,649 shares of Castle Biosciences worth $284K as of Q4 2023.
  • DFPG Investments sold 766 Castle Biosciences shares in Q4 2023, an estimated $13.5K.
  • Castle Biosciences made up 0.02% of DFPG Investments's portfolio in Q4 2023, its #527 holding.
  • DFPG Investments first reported a position in Castle Biosciences in Q2 2023 and has held it in 3 quarters since.
  • 153 funds tracked by Wall St. Rank held Castle Biosciences as of Q4 2023.

Based on DFPG Investments's 13F filing for Q4 2023, filed 10 Jan 2024.